US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 70.100
  • -0.190-0.27%
Close Oct 1 16:00 ET
13.35BMarket Cap53.11P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical Q2 2024 Earnings Date

Currency：USDAug 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
664.01M
712.03M
+48.02M
Beat Est.
+11.55%
+19.61%
+7.23%
EPS
0.35
0.55
+0.20
Beat Est.
+19.83%
+89.66%
+58.27%
Analyst Rating
Buy

Sep 30, 2024

Biomarin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 22 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 733.154M--
--2024/Q3-- / 703.133M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--
Feb 22, 20242023/Q4646.207M / 636.926M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 733.154M--
--2024/Q3-- / 703.133M--
Aug 5, 20242024/Q2712.029M / 664.008M--
Apr 24, 20242024/Q1648.833M / 651.814M--
Feb 22, 20242023/Q4646.207M / 636.926M--

Unlock Free Earnings Estimates

Biomarin Pharmaceutical Earnings Reports

  • Biomarin Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:38 ET

  • Biomarin Pharmaceutical | 10-Q: Q1 2024 Earnings Report

    Apr 26 14:04 ET

  • Biomarin Pharmaceutical | 10-K: FY2023 Annual Report

    Feb 26 13:36 ET

  • Biomarin Pharmaceutical | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 14:53 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      73.08%

    • Hold

      26.92%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data